CodonRX

CodonRX was founded during the midst of the COVID-19 pandemic, which served as a stimulus, forcing us to consider ways to improve the affordability and accessibility of high-quality, pharmaceutical products, globally. Our groundbreaking strain, patented as NCK2025, is the result of over a decade of rigorous scientific research focused on understanding the biology and genetics of the Lactobacillus acidophilus probiotic. From this, CodonRX was developed and combines the most advanced technologies in microbial biology to accelerate or promote general gut wellness by shielding the gut lining and eliminating inflammatory fatty acids. At CodonRX we believe products based on cutting-edge science should be accessible and affordable. We look forward to continuing this journey together and bringing this high impact probiotic to consumers.